Vitamin D requirements for the future—lessons learned and charting a path forward by Cashman, Kevin D.
Title Vitamin D requirements for the future—lessons learned and charting a
path forward
Author(s) Cashman, Kevin D.
Original citation Cashman, K. (2018) 'Vitamin D requirements for the future—lessons
learned and charting a path forward', Nutrients, 10(5), 533 (12pp). doi:
10.3390/nu10050533
Type of publication Article (peer-reviewed)
Link to publisher's
version
http://www.mdpi.com/2072-6643/10/5/533
http://dx.doi.org/10.3390/nu10050533
Access to the full text of the published version may require a
subscription.
Rights © 2018, the author. Licensee MDPI, Basel, Switzerland. This article
is an open access article distributed under the terms and conditions
of the Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/)
http://creativecommons.org/licenses/by/4.0/
Item downloaded
from
http://hdl.handle.net/10468/6229
Downloaded on 2019-01-07T05:40:26Z
nutrients
Review
Vitamin D Requirements for the Future—Lessons
Learned and Charting a Path Forward
Kevin D. Cashman ID
Cork Centre for Vitamin D and Nutrition Research, School of Food and Nutritional Sciences,
University College Cork, T12 Y337 Cork, Ireland; k.cashman@ucc.ie; Tel.: +353-21-4901317
Received: 6 April 2018; Accepted: 23 April 2018; Published: 25 April 2018


Abstract: Estimates of dietary requirements for vitamin D or Dietary Reference Values (DRV) are
crucial from a public health perspective in providing a framework for prevention of vitamin D
deficiency and optimizing vitamin D status of individuals. While these important public health
policy instruments were developed with the evidence-base and data available at the time, there are
some issues that need to be clarified or considered in future iterations of DRV for vitamin D. This is
important as it will allow for more fine-tuned and truer estimates of the dietary requirements for
vitamin D and thus provide for more population protection. The present review will overview some
of the confusion that has arisen in relation to the application and/or interpretation of the definitions
of the Estimated Average Requirement (EAR) and Recommended Dietary Allowance (RDA). It will
also highlight some of the clarifications needed and, in particular, how utilization of a new approach
in terms of using individual participant-level data (IPD), over and beyond aggregated data, from
randomised controlled trials with vitamin D may have a key role in generating these more fine-tuned
and truer estimates, which is of importance as we move towards the next iteration of vitamin D DRVs.
Keywords: vitamin D requirements; Dietary Reference Values; individual participant data
1. Introduction
An enormous body of research in relation to various aspects of vitamin D and health over the
last two decades has been instrumental in informing the estimates of dietary requirements for vitamin
D that have emerged since 2011. While in North America the terminology used to describe the
distribution of dietary requirements is Dietary Reference Intakes (DRI), its equivalent in Europe is
Dietary Reference Values (DRV) [1]; DRV is an abbreviation I will, for ease, use throughout this review
to represent both DRI and DRV, unless otherwise specified. These recent DRV are crucial from a public
health perspective in providing a framework for prevention of vitamin D deficiency and optimizing
vitamin D status of individuals [2]. In particular, DRV underpin the core goal of dietary assessment,
which is to determine if the nutrient intakes of an individual or group are meeting the needs of
that individual or group. While these are essential public health policy instruments developed with
the evidence-base and data available at the time, there are some issues that need to be clarified or
considered in future iterations of vitamin D DRV. This is important as it will allow for more fine-tuned
and truer estimates of the dietary requirements for vitamin D and thus provide for more population
protection. In particular, utilization of a new approach in terms of using individual participant-level
data, over and beyond aggregated data, from randomised controlled trials (RCTs) with vitamin D may
have a key role in generating these more fine-tuned and truer estimates. Consideration and clarification
of some of the issues around DRV derivation for vitamin D will certainly represent ‘changing times for
vitamin D and health’ in terms of dietary vitamin D requirements. The present review will highlight
some of the clarifications needed and the potential of the newer approach to analyze data as we move
towards the next iteration of DRV for vitamin D.
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2. Lack of Clarity and Consistency of Definition May Be an Achilles’ Heel within Recent
Vitamin D DRV Exercises
In scientific research, meaningful definitions are essential for comparability and reproducibility [3].
Furthermore, it has been suggested that to take effective public health measures, solid monitoring
and evaluation programmes are necessary, for which the definition of the concept must be clear [3].
Within the context of DRV for vitamin D, defining one’s terms is also a key step.
The Institute of Medicine (IOM) in the US and the European Food Safety Authority (EFSA) both
have published excellent overviews, or guides, to nutrient requirements in general [4,5]. The IOM’s
DRI and EFSA’s DRV, both include an (Estimated) Average Requirement (EAR/AR), Recommended
Dietary Allowance (RDA in the DRI) or Population Reference Intakes (PRI in the DRV), Adequate
Intake (AI), and Tolerable Upper Intake Level (UL) (see Table 1). Of the four values in common
within both sets of DRVs, the EAR and RDA (or their equivalents) deserve particular attention
in light of their key role in ensuring nutritional adequacy of groups and individuals, respectively.
The definitions provided by IOM and EFSA for their constituent DRI and DRV, respectively, are
provided in Table 1 [4–7]. Despite this, however, the interpretation and application of these definitions
has led to confusion and debate internationally which lessens the public health impact of some of these
vitamin D DRVs. The following will overview a number of areas where clarification of the definitions,
and their interpretation and application, would benefit future iterations of the vitamin D DRVs:
2.1. The Average Daily Nutrient Intake Level
Even the simple word ‘average’ within the IOM’s definitions of EAR and RDA can lead to a
level of confusion. In the context of the EAR, it is ‘the average daily nutrient intake level that is
estimated to meet the requirements of half of the healthy individuals in a particular life stage and
gender group’ [4,6]. Thus, the fact that it is an intake intended to meet requirements of half of the
healthy individuals (i.e., 50%; see Figure 1) puts the word ‘average’ in the title. The use of the word
‘average’ within the EAR definition proper, as well as that of the RDA (covering the needs of 97.5%
of the healthy individuals) (see Table 1), relates to the level of vitamin D intake each day, on average
over a period of time (e.g., a week or longer), which is estimated to meet the requirements. Thus, this
‘average’ over the period of time within an individual takes account of expected variability in the
intake of vitamin D in a person’s diet arising from his/her food choice and consumption patterns.
There can be confusion around the application or interpretation of the ‘average intake’ element
of the RDA definition. In general, RDAs, and their international equivalents, are intended for
ensuring nutritional adequacy of individuals more so than groups. EFSA, in their 2010 opinion,
have suggested that the PRI (their RDA equivalent, see Table 1) is an intake level that covers the
requirement of 97–98% of all individuals when requirements of the group have a normal distribution
(see Figure 1b); it should therefore not be used as a cut-point for assessing nutrient intakes of groups
because a certain overestimation of the proportion of the group at risk of inadequacy would result [5].
Despite this, the Nordic Council of Ministers (NORDEN), for example, when setting recommendations
for their populations have suggested that the Recommended Intake (RI; their RDA equivalent) is
appropriate for an average intake of a group expressed per day over a period of one week or more [8].
Possibly unintentionally, the IOM in the manner by which they derived their RDA have established an
average intake which will keep serum 25(OH)D concentration of a group above the 50 nmol/L target
threshold ([6] and see below).
Clarification #1. Going forward there is a need to be more explicit in the definition of the RDA, and
its equivalents, in particular on what is intended by the ‘average intake’, e.g., an average intake of
an individual over a period of time (e.g., a week or longer). If this is the intended meaning, or if
otherwise–it should be specified.
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Table 1. Definitions for the constituent Dietary Reference Intakes and Dietary Reference Values.
Institute of Medicine’s Dietary Reference Intakes [4,6] European Food Safety Authority’s Dietary ReferenceValues [5,7]
Estimated Average Requirement (EAR): The average daily
nutrient intake level that is estimated to meet the
requirements of half of the healthy individuals in a
particular life stage and gender group.
Average Requirement (AR): The level of (nutrient) intake
estimated to satisfy the physiological requirement or
metabolic demand, as defined by the specified criterion
for adequacy for that nutrient, in half of the people in a
population group, given a normal distribution
of requirement.
Recommended Dietary Allowance (RDA): The average daily
dietary intake level that is sufficient to meet the nutrient
requirements of nearly all (97.5 percent) healthy
individuals in a particular life stage and gender group.
Population Reference Intake (PRI): The level of (nutrient)
intake that is adequate for virtually all people in a
population group. On the assumption that the individual
requirements for a nutrient are normally distributed
within a population and the inter-individual variation is
known, the PRI is calculated on the basis of the AR plus
twice its standard deviation (SD). This will meet the
requirements of 97.5% of the individuals in
the population.
Adequate Intake (AI): The recommended average daily
intake level of a nutrient based on observed or
experimentally determined approximations or estimates
of intakes that are assumed to be adequate for a group
(or groups) of apparently healthy people; used when the
RDA cannot be determined.
Adequate Intake (AI): The value estimated when a PRI
cannot be established because an AR cannot be
determined. An Adequate Intake is the average observed
or experimentally determined approximations or
estimates of nutrient intake by a population group
(or groups) of apparently healthy people that is assumed
to be adequate.
Tolerable Upper Intake Level (UL): The highest average
daily nutrient intake level that is likely to pose no risk of
adverse health effects to almost all individuals in the
general population. As intake increases above the UL, the
potential risk of adverse effects may increase.
Tolerable upper intake level (UL): The maximum level of
total chronic daily intake of a nutrient (from all sources)
judged to be unlikely to pose a risk of adverse health
effects to humans.
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Figure 1. (a) The placement of (Estimated) Average Requirement [EAR(AR)] and Recommended 
Dietary Allowance (Population Reference Intakes) [RDA(PRI)] on the distribution of nutrient 
requirements within a population, as per the Institute of Medicine and European Food Safety 
Authority, and (b) and normal requirement distribution of hypothetical nutrient including percentile 
rank (taken from [4]).  
2.2. Serum 25(OH)D Thresholds Underpinning Dietary Requirement Estimates 
Estimation of vitamin D intake requirement values, such as the EAR or RDA, is made more 
complex because they are established as usual intakes of vitamin D aimed to achieve specified serum 
25(OH)D target concentrations in 50% or 97.5% of the population, respectively. The IOM indicated in 
Figure 1. (a) The placement of (Estimated) Average Requirement [EAR(AR)] and Recommended
Dietary Allowance (Population Reference Intakes) [RDA(PRI)] on the distribution of nutrient
requirements within a population, as per the Institute of Medicine and European Food Safety Authority,
and (b) and normal requirement distribution of hypothetical nutrient including percentile rank
(taken from [4]).
2.2. Serum 25(OH)D Thresholds Underpinning Dietary Requirement Estimates
Estimation of vitamin D intake requirement values, such as the EAR or RDA, is made more
complex because they are established as usual intakes of vitamin D aimed to achieve specified serum
25(OH)D target concentrations in 50% or 97.5% of the population, respectively. The IOM indicated
in 2011 that the data available to its Vitamin D and Calcium DRI committee did not lend themselves
to use the standard process of DRI development, which is reliant on a normal distribution and the
ability to determine an EAR intake value, and subsequently the RDA intake value, i.e., two standard
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deviations (SDs) above the EAR [6]. Instead, based on the availability of data, the committee used
25(OH)D concentrations to stimulate a dose–response relationship for vitamin D intake and bone
health. This has also been a further source of divergence in the interpretation of the definition of the
EAR and RDA. For example, NORDEN, following its review of the evidence base, decided that the
physiological requirement for vitamin D in terms of bone health would mainly be met at a serum
25(OH)D concentration of 50 nmol/L [8]. Therefore, the EAR and RDA-equivalent recommendations
they established (called AR and RI values, respectively) would maintain serum 25(OH)D concentrations
over their specified 50 nmol/L in at least 50% and 97.5% of individuals, respectively [8].
In contrast, the IOM, who also used bone health outcomes as their chosen criterion, applied
the conventional two SDs first and foremost to the serum 25(OH)D concentration underpinning the
dietary requirement estimates [6]. For example, for adults the IOM suggested that a serum 25(OH)D
concentration of 50 nmol/L would meet the needs of nearly all (97.5%) individuals, and assuming
a normal distribution of requirements, a serum level of 40 nmol/L was set as being consistent with
a median requirement (i.e., less two coefficients of variation (of 10% each), as a proxy for the two
SDs). Of note, for children and adolescents, they did the reverse in which they suggested that a serum
25(OH)D concentration of 40 nmol/L covered the median requirement, and application of the two
SDs brought this up to 50 nmol/L. The IOM coined the terms ‘EAR-like’ and ‘RDA-like’ for these
underpinning serum 25(OH)D concentrations, to distinguish from EAR and RDA, respectively, which
as the definitions dictate, are vitamin D intake values [6].
The EFSA panel who recently established their DRV for vitamin D in Europe, after taking into
account the overall evidence and uncertainties for adults, infants and children, considered that there
was sufficient evidence for an increased risk of adverse musculoskeletal health outcomes at serum
25(OH)D concentration below 50 nmol/L [7]. Thus, the panel concluded that a serum 25(OH)D
concentration of 50 nmol/L could be used as a target value to derive a DRV for vitamin D intake
for adults, infants, children and pregnant women. Of note, however, they did highlight that the
setting and analyses of the available studies do not allow a conclusion to be drawn as to whether this
concentration should be achieved by about half of (i.e., EAR-like) or most subjects (i.e., RDA-like) in
the population [7].
Clarification #2. If serum 25(OH)D concentrations are to be used in future iterations of vitamin D
DRV to underpin the establishment of EARs and RDAs, or their equivalents, it would be important to
consider whether one concentration which is deemed to provide for sufficient vitamin D status should
be selected (as per NORDEN [8]) or whether a concentration which is deemed to cover the median
requirement should be used to which two SDs could be added to establish that covering the needs of
97.5% of individuals (as per IOM [6]).
2.3. From a Serum 25(OH)D Threshold to an EAR Intake Value for Vitamin D
The step by which the ‘EAR-like’ and ‘RDA-like’ serum 25(OH)D concentrations are used to
derive the EAR and RDA intake values, respectively, is potentially the one that has caused greatest
confusion and is the one most in need of clarification as we move forward toward future iterations of
DRV. Of less contention is the derivation of the EAR for vitamin D. As mentioned above, NORDEN
established their AR of 7.5 µg/day for adult men and women from vitamin D intake-serum 25(OH)D
dose-relationship data (see below) and using a serum 25(OH)D ≥50 nmol/L as indicative of sufficient
vitamin D status [8]. The IOM also used vitamin D intake-serum 25(OH)D regression analyses, but
selected a serum 25(OH)D concentration of 40 nmol/L, and established an EAR of 10 µg/day for those
aged one year and upwards [6]. In both exercises, the regression analyses using group mean data
from several winter-based vitamin D RCTs (referred to as the ‘standard meta-regression approach’)
performed at northerly latitudes facilitated a derivation of an EAR estimate based on use of the median
regression line (covering 50th percentile and underpinning an EAR) (see Figure 2a). As the collection of
vitamin D RCTs used in the two exercises differed, we used the dataset from our recent meta-regression
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analysis [9] to illustrate the impact of the two different serum 25(OH)D target concentrations (40 versus
50 nmol/L) underpinning the EAR.
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Using 50 nmol/L as the serum 25(OH)D threshold concentration, our EAR estimate of 8.8 µg/day
(Table 2) is very similar to NORDEN’s AR of 7.5 µg/day, even though the collection of RCTs differed.
These estimates should in theory maintain 50% of individuals with serum 25(OH)D above 50 nmol/L
in winter (the other 50% could fall below this). In contrast, using the 40 nmol/L as the target
threshold yielded our EAR estimate of 3.7 µg/day. IOM, using the 40 nmol/L, established a much
higher EAR of 10 µg/day [6]. However, it is important to note that an intake of 10 µg/day in their
regression modelling was associated with a predicted mean circulating 25(OH)D level of 59 nmol/L
in children and adolescents, young and middle-aged adults. The DRI committee rationalised this by
acknowledging the considerable uncertainty in the simulated dose-response relationship that needed
to be taken into account, and accordingly selected the estimated intakes needed in a fashion that would
err on the side of the specified intake “overshooting” the targeted serum value to ensure that the
specified levels of intake achieved the desired serum 25(OH)D levels of 40 nmol/L [6].
Table 2. Comparison of the EAR and RDA estimates using two different serum 25(OH)D targets.
Ser ( H)D Concentration EAR Estimate (µg/day) 1 DA Estimate (µg/day) 2
40 nmol/L 3.7 -
50 nmol/L 8.8 12.7
1 Coveri the vitamin D needs of 50% of individuals; 2 Covering the vitamin D needs of 97.5% of individuals.
2.4. From Serum 25(OH)D Thresholds into the RDA Intake Value
Beyond the EAR, clarity on the derivation of the RDA from the target serum 25(OH)D
concentration is of key importance and in this step of the process, there has been much debate.
Again, while NORDEN and IOM both based th ir RDA values based on the vita in D int ke-serum
25(OH)D dose-rel tionship data (and bo used 50 nmol/L as the basis), the former establish d an
intake of 10 µg/d y [8], while the latter established 15 µg/day for tho e ag d 1–70 (20 µg/day for
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those aged 71+ years) [6]. Before discussing the sources of confusion around how these estimates were
derived, it might be worth re-emphasising how the RDA is used for assessment of nutrient intake.
The RDA intake value is set at a level that meets or exceeds the actual nutrient requirements of
97–98% of individuals in a given life stage and gender group. Thus, at this level of intake, there is
a 2–3% probability of an individual not meeting his or her requirement (Figure 1b). The RDA has
traditionally been adopted as the appropriate reference for planning intakes for individuals [4]. If one
assumes a hypothetical individual X has undergone a dietary assessment, their practitioner works
under the assumption that the RDA will achieve a serum 25(OH)D concentration of≥50 nmol/L in this
individual, irrespective of where this person actually resides within the distribution of requirements
below the 97.5th percentile (see Figure 1). Thus, the RDA becomes the intake target in terms of
dietary assessment as it will minimize the risk of inadequacy for that individual [4]. This is different
entirely from suggesting that a group of individuals (e.g., population or population-subgroup) will
be recommended/expected to consume the RDA. In a similar vein, the IOM, as a follow-up to their
2011 DRI report, went on to issue an announcement to clarify how the RDA for vitamin D was
determined [10]. This statement highlighted that while the RDA, by definition, meets the requirements
of 97.5% of the population, the goal is not, and should not be, to assure that 97.5% of the population
exceeds the serum 25(OH)D value linked to the RDA (i.e., 50 nmol/L). They suggest doing so would
shift the distribution to a higher level, and this could be associated with increased risk for potential
adverse effects for some within the distribution [10].
In terms of the mechanics as to how the IOM and NORDEN established their RDA values, both
used the lower 95% confidence interval (CI) of the median regression line of the vitamin D intake-serum
25(OH)D dose-relationship as a means of predicting the RDA intake (see Figure 2a for an example).
As can be seen from Table 2, using the dataset from our meta-regression analysis [9] yielded an
RDA estimate of 12.7 µg/day, not too dissimilar to that suggested by NORDEN (10 µg/day) or IOM
(15 µg/day) for adults [6,8]. It should be noted again that the IOM estimate, as with the EAR estimate,
erred on the side of caution in that the vitamin D intake of 15 µg/day would over-shoot the targeted
serum 25(OH)D concentration of 50 nmol/L [6]. However, importantly we had indicated shortly after
these IOM recommendations were issued, that if the expectation of the RDA intake estimate, derived
by this standard meta-regression approach, is that it is an intake of vitamin D which is sufficient to
cover the needs of 97.5% of individuals–it would fail to provide this level of protection [11]. The RDA
(or equivalent) intake generated from the 95% CI of the median regression line represents an intake
for which there is 95% surety it will maintain 50% of individuals over the target serum 25(OH)D
concentration of 50 nmol/L. Thus, for example, if the above-mentioned individual X happens to have a
need greater than that of the average person (i.e., 50 percentile), consuming 15 µg/day may not achieve
a serum 25(OH)D concentration of 50 nmol/L. An intake that is capable of maintaining serum 25(OH)D
concentration ≥50 nmol/L up at the 97.5th percentile of individuals, requires that it uses the median
intake but plus 2 SDs beyond that, as per more conventional use of an RDA (Figure 1b). Deriving this
latter estimate is not feasible at present from the type of standard meta-regression analyses that IOM
or NORDEN have done of late because while such analyses, based on aggregate (group mean) data,
perfectly captures the median response (and can add the 95% CI), they are not able to add the two
required SDs, as information on the between-individual variability is not accessible [2,9,11]. Thus,
while ideal for establishing an EAR, the standard meta-regression approach is not ideal for deriving
an RDA.
2.5. Moving Away from Use of Aggregate Data from Vitamin D RCTs in Favour of Their Individual Data for
the Estimation of the RDA for Vitamin D
It is only when one uses the data from individuals within an RCT, or even better a collection of
RCTs (see below), does the analyses allow one to capture the needed variability data and predict the
intakes at the 97.5th percentile (mean + 2 SDs, i.e., the RDA). It does this by generating the lower 95%
prediction interval from the data modelling (Figure 2b). This regression analysis based on individual
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participant data was the approach used by the Scientific Advisory Committee on Nutrition (SACN) in
the UK for their recent age-group specific vitamin D DRVs [12]. The 95% prediction interval has been
explained as an approximation of the interval that would allow for estimation of the requirements
for 95% of individuals in the overall population [7]. Interestingly, the National Academy of Sciences
in the US following a two-step exercise in which independent panels undertook a review process of
suggested potential mathematical and statistical errors in the 2011 IOM report, clarified that the DRI
committee did not use such a predication approach, but rather relied on the ‘overshoot’ arising from
use of the 95% CI, mentioned above, to capture uncertainty [13]. Applying the lower 95% CI will help
to overshoot these thresholds but will go no-where near replicating the requirement out at the 97.5th
percentile, as we have demonstrated recently in a comparison of regression models using empirical
data [9]. We showed that the usual vitamin D intake estimate needed to ensure a serum 25(OH)D
≥50 nmol/L up to and including the 97.5th percentile (using individual data, i.e., the ‘true RDA’ in
Figure 3) is 30.9 µg/day, while that generated by use of the lower 95% CI of the median of the group
mean response of the same dataset is 12.7 µg/day. This becomes very important when using these DRV
to assess the vitamin D intake of an individual. For example, the IOM suggest that if an observed usual
mean intake of an individual is between the EAR and the RDA, this probably needs to be improved
(because the probability of adequacy is more than 50 percent but less than 97.5 percent) [4]. Only if
intakes have been observed for a large number of days and are at or above the RDA should one have a
high level of confidence that the intake is adequate [4]. Thus, using 12.7 µg/day versus 30.9 µg/day,
as the true RDA will have a major impact.
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than the ‘True RDA’ is the estimated derived by use of the lower 95% prediction interval from the
regression analysis. UL, Tolerable Upper Intake Level for vitamin D.
Interestingly, the EFSA Panel considered that the available evidence did not allow the setting of
ARs and PRIs for it i i ste c se to set AIs for all population groups [7]. However,
in setting their AIs, EFSA acknowledged the i portance f si t e l er 95 prediction interval
approach in their eta-re ressi l s s [ ]. sing data from a large collection of vitamin
D RCTs tried to include r x t et ee -i i i l vari ilit ithin their meta-regression
analyses by using data on serum 25(OH)D variability but fro five population-based stu ies [14].
While this represents variability in serum 25(OH)D amongst individuals within a population, it is not
the variability in response of serum 25(OH)D to increased vitamin D intake within individuals. This can
be illustrated by their vitamin D intake estimate for 50 nmol/L at the 97.5th percentile (i.e., using their
approac towards generating a lower 95% prediction interval) being only 16.1 µg/day [7].
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Clarification #3. In terms of the RDA, there is a pressing need to revisit what we mean by the dietary
intake level that is sufficient to meet the nutrient requirements of nearly all (97.5 percent) healthy
individuals in a particular life stage and gender group, and specifically if we wish that such a value
has the inherent confidence that it can cover the needs of all but 2–3% of such individuals. How this
intake value is derived mathematically is also of key importance.
3. RCT Data Sharing Is Key to New DRVs for the Future
EFSA have suggested that one advantage of the standard meta-regression approach (as used by
themselves, IOM and NORDEN) is the representativity, by considering several studies from various
populations in different contexts, instead of relying on specific data from one specific study undertaken
in a particular context [7], as was done by SACN for three age-groups [12]. However, and as discussed
above, EFSA also indicated that by using group means from such studies, the information on the variability
between individuals is diminished, which complicates the setting of an RDA [7]. Between-participant
variability is crucial for estimating individual recommendations, such as the RDA [9].
To test the potential of such an approach, we recently undertook an IPD-based meta-regression
using individual subject data from selected winter-based RCTs of the vitamin D intake–serum 25(OH)D
dose-response [9]. A collection of seven, high-quality RCTs, where raw data were available to us, was
included in the analysis (n = 883 individuals, ranging in age group from four years-olds to 65+ years),
all implemented using the same study design, analytical platform for serum 25(OH)D and dietary
assessment method [9]. These first IPD-derived estimates were shown to be considerably different
from those of the agencies that used a standard meta-regression to analyze the vitamin D intake-serum
25(OH)D dose-response relationship, due to the inability of such standard meta-regression to capture
between person-variability appropriately.
It has been stressed that IPD analyses are not without their challenges, including being resource
intensive. The issue of limited availability of data for some studies could introduce bias [15]. Another
option that has been suggested is to collaborate with other research groups and agree to pool resources
to answer specific questions [16]. This is the approach adopted in our recent work which allowed us to
secure serum samples for re-analysis of 25(OH)D and remove some of the method-related confounding
that is likely intrinsic in DRV estimates to-date [9]. However, this could be considered the gold-standard
approach and even if re-analysis of 25(OH)D is not feasible, the IPD using existing 25(OH)D data is
still better than standard meta-regression analyses based on aggregate data. To underscore this notion,
in the present work we took the data from our recent IPD versus standard meta-regression analyses,
which was all based on standardized serum 25(OH)D data [9], and we applied the IPD analysis again
but this time on the original non-standardized serum 25(OH)D data. As can be seen in Table 3, while
the difference between the estimates from the standard meta-regression analyses based on aggregate
data and that from the IPD analysis (both based on standardized serum 25(OH)D data) is significant,
the estimates from the IPD analyses based on standardised and non-standardised 25(OH)D data are
very similar, at least for this collection of RCTs.
Table 3. The RDA estimates for vitamin D as derived using different regression modelling approaches.
Regression Modelling Approach RDA Estimate (µg/day) 1
Standard meta-regression (standardized 25(OH)D) 15.8
IPD meta-regression (standardized 25(OH)D) 28.8
IPD meta-regression (non-standardized 25(OH)D) 28.4
1 Covering the vitamin D needs of 97.5% of individuals.
Thus, gathering the serum 25(OH)D data from identified RCTs based on their original
measurement methodology would suffice to undertake these IPD analyses, if standardisation of serum
25(OH)D data, as the gold standard, is not feasible. This may be important in a wider context, where
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the availability of samples in addition to data from RCTs identified in the systematic review component
of the IPD meta-regression approach may not always be feasible and again could introduce bias.
The overall data sharing approach, however, may point towards an infrastructural requirement in
that the instigator of such collaborative IPD analyses would need to be sufficiently expert in soliciting
and handling the data as well as performing the regression modelling to derive the DRV estimates.
This new approach may well benefit from the generation of formal guidelines detailing the steps
needed. This might also raise awareness among potential collaborators of the need to also have good
quality data on the ‘total vitamin D intake’ estimates (i.e., the summation of dietary vitamin D as well
as assigned dose within the RCT) for all participants within their vitamin D RCTs. Going forward
two important underpinning infrastructures which would enhance this aspect of IPD analyses is the
standardisation of the assessment of habitual vitamin D intakes as well as standardisation of food
composition data, as outlined previously [17].
This type of collaborative approach aligns with emerging drive towards using larger datasets,
or ‘big data’, to help clinicians, policymakers, and the academic community evaluate an expanding
evidence base with a view towards guidelines and recommendations. This IPD approach can also be
tailored to different settings by altering the criteria for inclusion of the relevant vitamin D RCTs.
For example, as more vitamin D RCTs have been published in children, pregnancy and ethnic
population subgroups over recent years, tailored IPD analyses could be conducted to investigate
the vitamin D dietary requirements for these specific subgroups.
Nutrient intake can pose a dual risk to health, due either to inadequate or excessive
consumption [18]. While the benefits of the IPD-based approach are clear in terms of estimating
the EAR and RDA to protect against vitamin D inadequacy, it also has an additional advantage in
that its estimates can inform safety considerations. For example, while the lower prediction interval
within the regression modelling yields estimates for the RDA, the higher prediction interval (Figure 2a)
can be used to indicate the serum 25(OH)D concentrations achieved by the top 2.5th percentile of
the population at that RDA intake and whether that concentration is in excess of 125 nmol/L, which
the IOM suggest, if sustained, might be a reason for some concern [6]. Using our IPD-based ‘true’
RDA estimate of 28.8 µg/day (Table 3), the highest 2.5th percentile would achieve a serum 25(OH)D
concentration of 110 nmol/L, and a vitamin D intake of ~38 µg/day would be needed before a serum
25(OH)D of 125 nmol/L would be breached by this 2.5th percentile (unpublished data). It should be
noted, however, that the UL for vitamin D (i.e., the maximum level of total chronic daily intake of
vitamin D (from all sources) judged to be unlikely to pose a risk of adverse health effects to humans)
is the priority guidance in terms of safety of high vitamin D intakes [6,19]. While the RDA estimate
from the IPD-based approach (~28 µg/day) is much closer to the UL than the RDA estimate derived
from the standard aggregate-based method (see Figure 3), it is still well below the UL for vitamin D for
children and adults, in the range 50–100 µg/day, depending on age-group, as established by EFSA [19]
and the IOM [6].
Lastly, it is also important to emphasise that the IPD-based approach can be used under a
variety of different thresholds of serum 25(OH)D. As mentioned above, much of the evidence-base
underpinning the selection of a serum 25(OH)D threshold(s) in recent DRV exercises stemmed from
(musculo)skeletal health outcomes. An emerging body of evidence for a causal relationship between
vitamin D status and non-skeletal health outcomes could well lead to selection of a different serum
25(OH)D threshold in some future DRV exercise. As but one example to illustrate this point, a recent
IPD of 25 eligible vitamin D supplementation RCTs (total 10,933 participants, aged 0 to 95 years)
showed that vitamin D supplementation reduced the risk of acute respiratory tract infection by 12%
among all participants [20], and a number of the ongoing vitamin D ‘mega-trials’ have respiratory
disease as a pre-specified primary outcome measure, with these set to deliver their findings in the
coming few years. Should these new data on the role of vitamin D status in respiratory health alter
the serum 25(OH)D threshold selected to underpin an EAR and/or RDA, the IPD-based approach
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outlined in this review can just as easily be applied to this new threshold, as it has been applied by us
using serum 25(OH)D thresholds which to-date have been on the basis of bone health outcomes.
4. How Food-Based Approaches Together with New DRV May Help Populations Improve Their
Vitamin D Intake and Status
In terms of looking to the future, once some of the above-mentioned clarifications surrounding the
DRV definitions and their interpretation/application are provided, and IPD meta-regression analyses
is applied to the relevant vitamin D RCT data, we would have the most accurate DRV estimates of
vitamin D requirements to-date. This would have clear public health protection benefits, beyond those
from current DRV. While many, if not most, in the population will not have a dietary assessment, the
application of these future DRV for population guidance on vitamin D intake and strategies to achieve
the same, will also be of importance. For example, EFSA have suggested that the AR can be used
to estimate the prevalence of inadequate intakes of micronutrients within a group (population) [5],
if the distribution of nutrient intakes is normal, and intakes are independent from requirements.
The percentage of the population with a habitual daily nutrient intake lower than the AR is taken as
an estimate of the percentage of the population with probable inadequate intakes. For example, at a
median intake equal to the AR, 50% of a population group will have intakes that may be inadequate
for the chosen criterion of nutritional status [5]. Some of the panellists in the IOM DRI committee have
suggested that given the inherent variability, the appropriate approach to achieve a low prevalence of
vitamin D inadequacy within a population group—as verified by statistical modelling—is to shift the
intake distribution so that most of the population (97.5%) have vitamin D intakes above the EAR of
10 µg/day (not above the RDA) [21].
Even using the existing dietary vitamin D requirement estimates from our recent IPD analyses [9],
there seems to be a convergence of the different population status targets that would be attained
should the vast majority of individuals achieve the EAR intake of 10 µg/day. For example, 97.5% of
individuals would have serum 25(OH)D ≥25 nmol/L (as maybe the most conservative estimate of
vitamin D deficiency, and that used by SACN in their DRV [12]), about 95% would have serum 25(OH)D
≥30 nmol/L (IOM, NORDEN and EFSA’s definition of vitamin D deficiency [6–8]), and about 50% of
individuals would have serum 25(OH)D ≥50 nmol/L [9]. These IPD meta-regression projections are
supported by recent population study-based findings. For example, the recent standardized serum
25(OH)D data from the Finnish Health 2011 study shows that in a representative sample of 4051 adults
in Finland, a mean intake of 13 µg/day was associated with prevalence of serum 25(OH)D <30 nmol/L
was <1% [22]. It should be acknowledged, however, that the very low prevalence in this population
may have been aided by the fact that 63% of the sampling was done in August to October, when status
would have been better (remainder in November to February). It is also worth noting that for most
populations currently in Europe and North America, and likely beyond, between 50% and 100% of
individuals fail to meet this EAR target of 10 µg/day [23–26]. Thus, in order for most of the population
(97.5%) to achieve vitamin D intakes at or above 10 µg/day, strategic additions to the food chain will
be required, as reviewed elsewhere [2,18,27–29].
5. Conclusions
It is important to highlight that the nutritional requirements for vitamin D that have emerged since
2011 were, for the most part, on the basis of (musculo) skeletal health outcomes [6–8,12,30]. Future
iterations may well be based on different thresholds for 25(OH)D as scientific evidence accumulates
and strengthens globally, and in particular as non-skeletal effects of vitamin D make an ongoing
contribution to the discussion about thresholds for 25(OH)D that indicate a healthy vitamin D status.
That said, the required clarifications to definitions of DRV and/or their interpretation and application
as well as greater utilization and adoption of IPD meta-regression analyses will still pertain, thus
these should be considered now in preparation for the next iteration of DRV for vitamin D. One of
the information gaps and research needs as identified by the DRI committee in their 2011 report
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related to synthesizing evidence and research methodology, specifically the need to explore enhanced
methodologies for data synthesis [6]. The IPD meta-regression approach outlined in this review is
one such example of an enhanced methodology of key importance in terms of DRI development for
vitamin D going forward. The application of such an approach will have even greater value moving
forward when coupled with clarity of definition of some of the concepts guiding development of DRV
for vitamin D.
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